UCB has three products currently in phase III which are due to produce pivotal results in the next few years: brivaracetam for epilepsy, lupus treatment epratuzumab and romosozumab for osteoporosis.

Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...

United Community Banks (UCB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

As such, UCB’s recently-debuted, U.S.-based DTC rare-disease campaign Imagine Your Zillions supports its gMG treatment Zilbrysq. The effort is based on flipping the preconceived notions associated ...

Bottlerocket Social Hall partners with Upright Citizens Brigade, securing investment for a Pittsburgh comedy training center ...

Over the past decade or so, that has slowly but surely changed — first, Arcade Comedy Theater opened Downtown; then, more ...

We are proud to present, for the first time, the bimekizumab two-year results at EADV 2024," said Fiona du Monceau, Executive Vice President, Head of Patient Evidence, UCB. "These longer-term data ...

Upright Citizens Brigade is now a partner in Pittsburgh's Bottlerocket Social Hall and plans Pittsburgh training center.

Sept 24 (Reuters) - Biogen (BIIB.O), opens new tab and Belgian partner UCB (UCB.BR), opens new tab said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ahead of AbbVie’s Rinvoq and Skyrizi three months into its ...

Explore UCB stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest UCB price ...